Evidence map›Paper›PMID 38056427›Full record

ArticleCell metabolism2023

Early-life microbiota as a baby metabolic guardian.

Max Nieuwdorp, Melany Rios-Morales

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Max NieuwdorpDepartment of Internal and (Experimental) Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands; ACS Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Melany Rios-MoralesDepartment of Internal and (Experimental) Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands; ACS Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: m.riosmorales@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early-life microbiota have a crucial role in healthy development. Antibiotics, on the other hand, can disrupt this beneficial interaction and have been linked to increased adiposity in children. Shelton and collaborators went deeper into the mechanism by which microbiota protect against lipid metabolic dysfunction and diet-induced obesity. The results highlight the long-term metabolic risk of early antibiotic exposure.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAdiposityAnti-Bacterial AgentsChildHumansInfantObesityAnti-Bacterial Agents

Identifiers

PMID38056427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.